Back to UBS Group AG UBS Group AG

PLRXPLRX
24 quarters

Position history for UBS Group AGUBS Group AG's holdings in PLIANT THERAPEUTICS INC

UBS Group AG holds 571,760 shares of PLRX (PLIANT THERAPEUTICS INC), worth $651,806 as of 2026-Q2. The position was decreased (-46.0% shares). PLRX represents 0.0% of UBS Group AG's portfolio.

Current Value

$651,806

Current Shares

571,760

Total Value Change

+$594,806

Total Shares Change

+569,250

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
571,760
-46.0%
$651,8060.0%$1.14
0
2026-Q1
Decreased
1.1M
-0.4%
$1.3M0.0%$1.25
0
2025-Q4
Decreased
1.1M
-19.6%
$1.3M0.0%$1.21
0
2025-Q3
Decreased
1.3M
-50.0%
$2M0.0%$1.49
0
2025-Q2
Increased
2.6M
+0.0%
$3.1M0.0%$1.25
26
2025-Q1
Increased
2.6M
+321.1%
$3.6M0.0%$1.47
43
2024-Q4
Increased
628,281
+172.8%
$8.3M0.0%$12.79
44
2024-Q3
Increased
230,308
+51.3%
$2.6M0.0%$11.31
36
2024-Q2
Decreased
152,202
-58.3%
$1.6M0.0%$10.75
0
2024-Q1
Increased
365,064
+6.7%
$5.4M0.0%$14.90
29
2023-Q4
Increased
342,173
+26.4%
$6.2M0.0%$18.11
34
2023-Q3
Increased
270,804
+8855.2%
$4.7M0.0%$17.34
43
2023-Q2
Decreased
3,024
-79.2%
$54,7950.0%$18.26
0
2023-Q1
Increased
14,560
+169.9%
$387,2960.0%$26.54
38
2022-Q4
Decreased
5,395
-18.3%
$104,2860.0%$19.33
0
2022-Q3
Increased
6,600
+86.6%
$138,0000.0%$20.76
35
2022-Q2
Increased
3,537
+18.4%
$28,0000.0%$7.68
16
2022-Q1
Decreased
2,987
-71.1%
$21,0000.0%$7.08
0
2021-Q4
Increased
10,321
+434.8%
$140,0000.0%$13.74
24
2021-Q3
Increased
1,930
+38.1%
$32,0000.0%$16.48
18
2021-Q2
Increased
1,397
+55.9%
$41,0000.0%$28.20
19
2021-Q1
Decreased
896
-35.0%
$35,0000.0%$36.99
0
2020-Q4
Decreased
1,379
-45.1%
$32,0000.0%$23.33
0
2020-Q3
New
2,510
-
$57,0000.0%$23.74
32

Other major holders of PLRX: BlackRock Finance, Inc., PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used